Frank Danehy

Frank Danehy has extensive experience in the pharmaceutical industry, spanning over 20 years. Frank currently holds the position of Senior Scientist II at Scholar Rock since October 2019. Prior to this, they were a Principal Associate Scientist II at the same company from January 2016 to October 2019.

Before joining Scholar Rock, Frank worked at Alexion Pharmaceuticals, Inc. (previously Synageva Pharmaceuticals Biopharma) as a Research Scientist II from December 2013 to December 2015.

Frank's earlier work experience includes a role as a Research Scientist at Idenix Pharmaceuticals from September 2003 to September 2013. Here, they played a crucial role in setting up a biochemistry lab, developing purification protocols, and optimizing viral target expression.

Before Idenix Pharmaceuticals, Frank worked as a Research Scientist at Phylos Inc. from 2001 to 2003, where they developed a high-throughput method for protein refolding and implemented techniques to reduce PCR contamination.

Frank's career started at Anadys Pharmaceuticals in 1998, where they served as a Senior Associate Scientist. Their responsibilities included cloning and developing purification schemes for target proteins and sequencing expression constructs to ensure accurate purification.

Throughout their career, Frank Danehy has consistently demonstrated their expertise in protein research, optimization, and laboratory management.

Frank Danehy attended Boston College from 1983 to 1987. No specific degree or field of study information was provided.